Novartis Ag (NVS) Net Income towards Common Stockholders (2009 - 2026)

Novartis Ag has disclosed Net Income towards Common Stockholders across 18 years of filings, most recently posting $3.3 billion for Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders fell 19.23% year-over-year to $3.3 billion; the TTM figure through Jun 2026 stood at $22.5 billion (down 7.91% YoY), while the FY2025 annual figure was $14.0 billion, up 17.11% from the prior year.
• Net Income towards Common Stockholders came in at $3.3 billion for Q2 2026 at Novartis Ag, down from $4.5 billion in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $13.4 billion in Q4 2023 to a low of $1.7 billion in Q2 2022.
• Average Net Income towards Common Stockholders over 5 years is $4.9 billion, with a median of $3.6 billion recorded in 2024.
• Year-over-year, Net Income towards Common Stockholders sank 59.69% in 2022 and surged 94.73% in 2024.
• Over 5 years, Net Income towards Common Stockholders stood at $7.2 billion in 2022, then soared by 85.16% to $13.4 billion in 2023, then declined by 13.5% to $11.6 billion in 2024, then decreased by 11.63% to $10.2 billion in 2025, then slumped by 68.13% to $3.3 billion in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $3.3 billion in Q2 2026, $4.5 billion in Q1 2026, and $10.2 billion in Q4 2025.